Alendronate News
Prevent Bone Fractures After Menopause
A common drug may help prevent bone fractures in postmenopausal women.
Atlast a Solution to Bone Mass Loss in Postmenopausal Women!
This finding applies to women who have started to lose their bone mass but have no fractures (primary prevention), as well as those who have lost significant bone mass and/or have had fractures (secondary prevention).
Amgen says denosumab vs Fosamax trial meets goals
Amgen Inc said on Thursday that a head-to-head trial comparing its experimental osteoporosis drug denosumab to Merck & Co Inc's Fosamax in post-menopausal women with low bone mineral density met all of its goals.
Medical Edge: Medication options if bone density improves
Dear Mayo Clinic: Eleven years ago, I was diagnosed with osteoporosis. Since then, I have taken Fosamax, calcium citrate and vitamin D. Regular bone density tests have shown improvement to osteopenia. Now, at age 75 and in...
Popular Osteoporosis Drugs Triple Risk of Bone Necrosis
A University of British Columbia (UBC) and Vancouver Coastal Health Research Institute (VCHRI) study has found that a popular class of osteoporosis drugs nearly triples the risk of developing bone necrosis, a condition that can...